We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 2M6 market cap is 103.78B. The company's latest EPS is USD 2.8263 and P/E is 29.90.
| Year End 28 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 30.56B | 28.91B | 30.12B | 31.69B | 31.39B |
| Operating Income | 5.91B | 4.66B | 4.32B | 5.84B | 5.49B |
| Net Income | 4.63B | 4.79B | 3.61B | 5.04B | 3.76B |
| Year End 28 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 89.69B | 90.69B | 93.08B | 90.98B | 90.95B |
| Total Liabilities | 39.48B | 39.82B | 41.48B | 38.26B | 39.28B |
| Total Equity | 50.21B | 50.87B | 51.6B | 52.72B | 51.67B |
| Year End 28 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7.01B | 7.23B | 6.24B | 7.35B | 6.04B |
| Investing | -774M | -3.2B | -2.87B | -1.66B | -3.49B |
| Financing | -5.43B | -4.2B | -4.14B | -5.34B | -4.96B |
| Market Cap | 103.78B |
| Price to Earnings Ratio | 29.90 |
| Price to Sales Ratio | 3.58 |
| Price to Cash Ratio | 72.82 |
| Price to Book Ratio | 2.17 |
| Dividend Yield | - |
| Shares Outstanding | 1.33B |
| Average Volume (1 week) | 3.28k |
| Average Volume (1 Month) | 3.32k |
| 52 Week Change | -5.19% |
| 52 Week High | 83.44 |
| 52 Week Low | 64.96 |
| Spread (Intraday) | 0.24 (0.31%) |
| Company Name | Medtronic Plc |
| Address |
20 lower dublin D02 XH02 |
| Website | https://www.medtronic.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
